POST 18th_ELSF
​> ATTENDEES​
​​> INVESTORS​
> PRESENTERS​
​> SPONSORS​
​> SUPPORTERS​

Sachs Associates would like to say that we have enjoyed hosting you in-person and virtually and thank those who participated in our 18th Annual European Life Sciences CEO Forum (Sachs_ELSF). A special thank you goes to the excellent line-up of sponsors, chairs, panellists, and presenters who made such a broad and interesting programme possible. 

The ELSF has proven to be successful in supporting our community with over 430 people from 27 countries registered and nearly 2000 in-person & online meetings completed.   

Publicly available recordings of the sessions and presentations from the event will be uploaded to the SachsTV YouTube channel in April. 


We are looking forward to welcoming you again to our future events!

Confirmed Sponsors Included:

Presenting Companies Included:

Confirmed Keynote Speakers Included:

• “The Dragon’s Leap: How China’s Innovations Are Redefining the Future” by Darren Ji, Co-Founder, Chairman & CEO, Elpiscience Biopharmaceuticals Co. Ltd.
  

Confirmed Chairs & Speakers Included:

• Alain Martelli, Director, External Science Lead, Europe, Pfizer, Inc.
• Albert Seymour, President & CEO, Seamless Therapeutics, Inc.
• Alexander Gebauer, Co-Founder & Executive Chairman, Galimedix Therapeutics, Inc.
• Andreas Pahl, CEO, Heidelberg Pharma AG
• Anne Grahl, Associate, Pureos Bioventures
• Astrid Maria Dahl, COO & Head of Europe, Innovent Biologics
• Avencia Sanchez-Mejias García, Co-Founder & CEO, Integra Therapeutics
• Boris Bogdan, Lead HCLS EMEA, Amazon Web Services
• Bryan Kobel, CEO, TC BioPharm Limited
• Cem Baydar, Independent Board Member, Strategic Advisor & Investment Officer, Independent
• Chandra Leo, Investment Advisor, HBM Partners AG
• Charlie Bailey, BD&L Transactions Head, Global Health, Novartis AG
• Darren Ji, Co-Founder, Chairman & CEO, Elpiscience Biopharmaceuticals Co. Ltd.
• David Venables, CEO, Laverock Therapeutics Ltd.
• Davor Kosanic, CEO, Reconnect Labs AG
• Diana Pignalosa, Head of Strategic Partnering, Search & Evaluation, Debiopharm International SA
• Esteban Pombo-Villar, CTO, TargImmune Therapeutics AG
• Esther Melo, Director BD&L, F. Hoffmann-La Roche AG
• Evonne Sepsis, Managing Director, ESC Advisors
• George Tzircotis, Associate Director, BD, Cancer Research Horizons
• Georgia Frost, Senior Associate, Dementia Discovery Fund 2 L.P. (SV Health Investors)
• Gregor Macdonald, VP, Head of BD&L, Search & Assessment, H. Lundbeck A/S
• Gregory Rall, Deputy Head, Innovation & Technology, InvestHK
• Jenny Laird, VP, Search & Evaluation Neuroscience, Eli Lilly and Company
• Jeremy Griggs, Executive Director, Search & Evaluation, GSK
• Jesus Baena, BD&L Transactions Oncology Director, Novartis AG
• Joachim Vogt, Director Search & Evaluation International, AbbVie, Inc.
• Johannes Virkkunen, Head of Division - Equity Investments, European Investment Fund
• Karen Wagner, Managing Partner, Ysios Capital
• Katharina Kreymborg, SVP, Curie.Bio
• Katya Smirnyagina, Senior Partner, Oxford Science Enterprises
• Kelly Curtin, Managing Director, Stifel
• Konstantin Petropoulos, CEO, Secarna Pharmaceuticals GmbH & Co. KG
• Laura Lane, VP of Lilly Ventures, Eli Lilly and Company 
• Marc Martinell, Co-Founder & CEO, Minoryx Therapeutics
• Marc-Olivier Turgeon, Senior Associate, Forbion
• Michael Altorfer, CEO, Swiss Biotech Association
• Michael Hübner, Director Early Innovation Partnering, Johnson & Johnson Innovation LLC
• Monika Paule, Co-Founder, CEO & Board Member, Caszyme, LLC
• Naveed Siddiqi, Senior Partner, Novo Holdings A/S
• Neil Torbett, CEO, PhoreMost Ltd.
• Nikolay Savchuk, Managing Partner, Torrey Pines Investment
• Olav Zilian, Senior Financial Analyst, Pictet & Cie SA
• Ole Mensching, Co-Founder & General Partner, Apollo Health Ventures
• Paolo Di Giorgio, Managing Director & CEO, Angelini Ventures S.p.A.
• Patrick Schwab, Senior Director, AI & Machine Learning, GSK
• Paul Hermant, Partner, Bird & Bird LLP
• Paul Vogel, Managing Director & VP of Research, AIRNA Corporation, Inc.
• Peter Llewellyn-Davies, CEO & CFO, invIOs GmbH
• Rainer Metzger, Head of Integrated Clinical Services, Medicover AB
• Rainer Strohmenger, Managing Partner, Wellington Partners
• Raj Airey, Founding Partner, Convergence Partners
• Reagan Jarvis, Co-Founder & CEO, Anocca AB
• Regina Hodits, Managing Partner, Wellington Partners
• Robert de Jonge, SVP, Head of Corporate Development, Mestag Therapeutics Ltd.
• Sarah Holland, President of Swiss Healthcare Licensing Group & CBO, CDR-Life AG
• Sean Kendall, Partner, ARCH Venture Partners
• Søren Møller, Managing Partner, Novo Holdings A/S
• Stephan Lensky, COO & CBO, EpimAb Biotherapeutics
• Stephanie Léouzon, Managing Director & Vice Chair of European Healthcare Investment Banking, Stifel
• Stephen Myatt, CEO, Macomics Ltd.
• Sylvie Ryckebusch, CBO, BioInvent International AB
• Tamas Schweighoffer, Co-Founding Partner, Forty51 Ventures AG
• Ted Fjällman, CEO, Flerie AB
• Thibaut Roulon, Senior Investment Director, Bpifrance
• Thierry Laugel, Managing Partner, Kurma Partners
• Thilo Schroeder, Managing Partner, Nextech Invest Ltd.
• Tim Lohoff, Senior Associate, Forbion
• Ulrich Wendt, Global Head Business Development Immunology & Inflammation, Sanofi
• Vanessa King, CEO, King Bioventures
• Victor Ma, Partner, Fontaine Capital
• Victoria English, Co-Founder & Editor of Evernow Publishing Ltd, publisher, MedNous
  

Silver Sponsor:

Bronze Sponsor:

Contributing Sponsors:

---

Supporters:

---

Participating Pharmas:

---

Financial, Advisory & Investors Attending:

3B Future Health Ventures
AFK & Partners Asset Management LLC
Ampleia
Amplitude Ventures
AMR Action Fund GP GmbH
Angelini Ventures S.p.A.
Apollo Health Ventures
ARCH Venture Partners
ARCHIMED
Asahi Kasei Ventures
Ascension Ventures
Atheneos Ventures LLC
AurorA Science Srl
Bergmann zur Hausen & Cie. GmbH
BERNINA BioInvest
BGV
BioMatch LLC
BioMedPartners AG
BiomedVC AG
Bioqube Ventures 
Bioscience Equity Partners
Biovision Ventures
BlackRock
BOHE Angel Fund
Bootstrap Europe
Bpifrance
BROTHERS & Partners Europe
Business Angels Switzerland
CARMA FUND Management GmbH
Convergence Partners
Cukierman & Co. Life Sciences
Curie.Bio
Debiopharm
Delin Ventures Ltd.
Dementia Discovery Fund 2 L.P. (SV Health Investors)
Digital Networks PLC
Eight Roads Ventures
Eliraz Ventures
EQT Life Sciences
ESC Advisors
European Investment Fund
Flerie AB
Fontaine Capital
Forbion
Forty51 Ventures AG
Fraser Partners
Generation Fund Life Sciences Fund I
GIBF
Gimv
GOLDTRACK Ventures GmbH
H.C. Wainwright & Co., LLC
HBM Partners AG
Health Care Advisory
High-Tech Gründerfonds Management GmbH
Innovestor Life Science
IPF Partners
Italian Angels for Growth (IAG)
JFG Life Sciences Foundation
Kerna Ventures
King Bioventures
Kurma Partners
Landmark Angels/Family Ofiice
Landmark BioVentures
LifeCare Partners GmbH
Lumira Ventures
M Ventures
M&G Advisors GmbH
M2Care
MEDKAP Investor Association
Mid Atlantic Bio Angels
MIG Capital
Mirabaud & Cie SA
Momentum Biotech LLC
MSQ Ventures
NEOM
Nextech Invest Ltd.
NG Bio
Novartis Venture Fund
Novo Holdings A/S
​
To View All - Click Here